PanTher Therapeutics is a privately-owned, early stage company in the pre-clinical phase that provides superior technologies for revolutionizing the treatment of solid tumors. By changing the route of administration, using novel localized drug-eluting systems able to provide mechanical support, we dramatically enhance chemotherapeutic response while improving quality of life. In addition, PanTher’s solution provides the socio-economic benefit of a more cost-effective management of healthcare.